- Arterioscler Thromb Vasc Biol 29:184350 Laviola L, Leonardini A, Melchiorre M, Orlando MR, Peschechera A, Bortone A, Paparella D, Natalicchio A, Perrini S, Giorgino F (2012) Glucagon-like peptide-1 counteracts oxidative stress-dependent apoptosis of human cardiac progenitor cells by inhibiting the activation of the c-Jun N-terminal protein kinase signaling pathway
The risk in humans is still unknown
Fat loss results are more gradual, but the safety and tolerability profile is well-characterized
But now, having the option of taking a pill is available
The body aches sometimes reported on tirzepatide and the anxiety some users experience do not appear to be more common on retatrutide, suggesting these effects are GLP-1/GIP mediated rather than glucagon-dependent